This technical analyst sees upside for S&P 500 in Q1 

Artificial intelligence is moving quickly into drug discovery as pharmaceutical and biotech companies look for ways to cut years off R&D timelines and increase the chances of success amid rising cost. More than 200 startups are now competing to weave AI directly into research workflows, attracting growing interest from investors. Converge Bio is the latest...

That’s according to a report Monday (Jan. 12) by Bloomberg News, which characterizes the move as part of a larger plan by Meta to reduce its focus on virtual reality products as it concentrates on other artificial intelligence (AI) wearables. The layoffs in the roughly 15,000-person division are expected this week, the report said, citing...